Gt Biopharma Stock Forecast

Sell candidate since Jul 31, 2026

The GT Biopharma, Inc. stock price fell by -4.65% on the last day (Friday, 31st Jul 2026) from $0.308 to $0.294. During the last trading day the stock fluctuated 3.67% from a day low at $0.283 to a day high of $0.294. The price has fallen in 7 of the last 10 days and is down by -17.53% for this period. Volume has increased on the last day by 174 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 597 thousand shares were bought and sold for approximately $175.11 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.274 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -8.19% during the next 3 months and, with a 90% probability hold a price between $0.251 and $0.453 at the end of this 3-month period.

GTBP Signals & Forecast

There are few to no technical positive signals at the moment. The GT Biopharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.316 and $0.410. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 18, 2026, and so far it has fallen -42.90%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). GT Biopharma, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for GT Biopharma, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0104 between high and low, or 3.67%. For the last week, the stock has had daily average volatility of 6.79%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GTBP) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect GT Biopharma, Inc. to open at $0.290, and during the day (based on 14 day Average True Range), to move between $0.275 and $0.312, which gives a possible trading interval of +/-$0.0361 (+/-13.10%) up or down from last closing price. If GT Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 13.10% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.343, some $0.0494 (16.83%) from the current price of $0.294, our system finds the risk reward not very attractive.

Is GT Biopharma, Inc. stock A Buy?

GT Biopharma, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Strong Sell candidate.

Current score: -5.101 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $0.290 ( 1.18%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk